Article: T-spot.TB outperforms tuberculin skin test in predicting tuberculosis disease

File Download Links for fulltext
(May Require Subscription)
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleT-spot.TB outperforms tuberculin skin test in predicting tuberculosis disease
AuthorsLeung, CC2
Yam, WC1
Yew, WW3
Ho, PL1
Tam, CM2
Law, WS2
Au, KF2
Tsui, PW2
KeywordsIfn-Γ Release Assay
Latent Tuberculosis Infection
Silicosis
Issue Date2010
PublisherAmerican Thoracic Society. The Journal's web site is located at http://ajrccm.atsjournals.org
CitationAmerican Journal Of Respiratory And Critical Care Medicine, 2010, v. 182 n. 6, p. 834-840 [How to Cite?]
DOI: http://dx.doi.org/10.1164/rccm.200912-1875OC
AbstractRationale: Silicosis is a well-recognized risk factor for tuberculosis (TB). Objectives: To compare T-Spot.TB with tuberculin skin test (TST) in predicting the development of TB. Methods:Male patients with silicosis without clinical suspicion of active TB, past history of TB, and treatment for latent TB infection (LTBI) were offered both T-Spot. TB and TST in the Pneumoconiosis Clinic of Hong Kong from 2004 to 2008, and followed prospectively until September 30, 2009, for development of TB. Measurements and Main Results: Active TB and culture- or histology-confirmed TB developed in 17 (5.5%) and 14 (4.5%) of 308 recruited subjects at an annual rate of 2,247 and 1,851 per 100,000 person-years, respectively. Active TB occurred in 7.4% (15 of 204) and 1.9% (2 of 104) of T-Spot. TB-positive and-negative subjects, respectively, whereas the corresponding figures for TST (cutoff 10 mm) were 6.4% (13 of 203) and 3.9% (4 of 205), respectively. Apositive T-Spot. TB test significantly predicted the subsequent development of active TB (relative risk, 4.50; 95% confidence interval, 1.03-19.68) and culture- or histology-confirmed TB (relative risk, 7.80; 95% confidence interval, 1.02-59.63). Consistent results were obtained after exclusion of subjects treated for LTBI and adjustment for potential confounders. TST did not significantly predict the development of active TB or culture- or histology-confirmed TB, irrespective of the cutoff values with or without exclusion of subjects treated for LTBI. Culture filtrate protein 10 spot count, but not early secretary antigenic target 6 spot count, was significantly associated with subsequent TB development. Conclusions: T-Spot. TB performs better than TST in the targeted screening of LTBI among patients with silicosis.
ISSN1073-449X
2011 Impact Factor: 11.08
2011 SCImago Journal Rankings: 1.008
DOIhttp://dx.doi.org/10.1164/rccm.200912-1875OC
ISI Accession Number IDWOS:000282162100017
Funding AgencyGrant Number
Pneumoconiosis Compensation Fund Board
University of Hong Kong
Funding Information:

Supported by research grants from the Pneumoconiosis Compensation Fund Board and from the University of Hong Kong UDF Project-Research Centre of Emerging Infection Diseases.

ReferencesReferences in Scopus
DC Field
Value
dc.contributor.authorLeung, CC
dc.contributor.authorYam, WC
dc.contributor.authorYew, WW
dc.contributor.authorHo, PL
dc.contributor.authorTam, CM
dc.contributor.authorLaw, WS
dc.contributor.authorAu, KF
dc.contributor.authorTsui, PW
dc.date.accessioned2012-08-08T08:51:38Z
dc.date.available2012-08-08T08:51:38Z
dc.date.issued2010
dc.description.abstractRationale: Silicosis is a well-recognized risk factor for tuberculosis (TB). Objectives: To compare T-Spot.TB with tuberculin skin test (TST) in predicting the development of TB. Methods:Male patients with silicosis without clinical suspicion of active TB, past history of TB, and treatment for latent TB infection (LTBI) were offered both T-Spot. TB and TST in the Pneumoconiosis Clinic of Hong Kong from 2004 to 2008, and followed prospectively until September 30, 2009, for development of TB. Measurements and Main Results: Active TB and culture- or histology-confirmed TB developed in 17 (5.5%) and 14 (4.5%) of 308 recruited subjects at an annual rate of 2,247 and 1,851 per 100,000 person-years, respectively. Active TB occurred in 7.4% (15 of 204) and 1.9% (2 of 104) of T-Spot. TB-positive and-negative subjects, respectively, whereas the corresponding figures for TST (cutoff 10 mm) were 6.4% (13 of 203) and 3.9% (4 of 205), respectively. Apositive T-Spot. TB test significantly predicted the subsequent development of active TB (relative risk, 4.50; 95% confidence interval, 1.03-19.68) and culture- or histology-confirmed TB (relative risk, 7.80; 95% confidence interval, 1.02-59.63). Consistent results were obtained after exclusion of subjects treated for LTBI and adjustment for potential confounders. TST did not significantly predict the development of active TB or culture- or histology-confirmed TB, irrespective of the cutoff values with or without exclusion of subjects treated for LTBI. Culture filtrate protein 10 spot count, but not early secretary antigenic target 6 spot count, was significantly associated with subsequent TB development. Conclusions: T-Spot. TB performs better than TST in the targeted screening of LTBI among patients with silicosis.
dc.description.natureLink_to_subscribed_fulltext
dc.identifier.citationAmerican Journal Of Respiratory And Critical Care Medicine, 2010, v. 182 n. 6, p. 834-840 [How to Cite?]
DOI: http://dx.doi.org/10.1164/rccm.200912-1875OC
dc.identifier.doihttp://dx.doi.org/10.1164/rccm.200912-1875OC
dc.identifier.epage840
dc.identifier.hkuros179786
dc.identifier.isiWOS:000282162100017
Funding AgencyGrant Number
Pneumoconiosis Compensation Fund Board
University of Hong Kong
Funding Information:

Supported by research grants from the Pneumoconiosis Compensation Fund Board and from the University of Hong Kong UDF Project-Research Centre of Emerging Infection Diseases.

dc.identifier.issn1073-449X
2011 Impact Factor: 11.08
2011 SCImago Journal Rankings: 1.008
dc.identifier.issue6
dc.identifier.scopuseid_2-s2.0-77957069528
dc.identifier.spage834
dc.identifier.urihttp://hdl.handle.net/10722/157605
dc.identifier.volume182
dc.languageeng
dc.publisherAmerican Thoracic Society. The Journal's web site is located at http://ajrccm.atsjournals.org
dc.publisher.placeUnited States
dc.relation.ispartofAmerican Journal of Respiratory and Critical Care Medicine
dc.relation.referencesReferences in Scopus
dc.subjectIfn-Γ Release Assay
dc.subjectLatent Tuberculosis Infection
dc.subjectSilicosis
dc.titleT-spot.TB outperforms tuberculin skin test in predicting tuberculosis disease
dc.typeArticle
Author Affiliations
  1. The University of Hong Kong
  2. Centre for Health Protection
  3. Grantham Hospital Hong Kong